Standard BioTools (FLB) Ratios
4 Followers
Standard BioTools Ratios
DE:FLB's free cash flow for Q3 2026 was $-6.16M. For the 2026 fiscal year, DE:FLB's free cash flow was increased by $0.00 and operating cash flow was $-6.16M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.19 | 5.70 | 1.45 | 4.81 | 1.45 |
| Quick Ratio | 4.01 | 5.09 | 1.26 | 4.31 | 1.03 |
| Cash Ratio | 1.09 | 2.53 | 0.47 | 1.87 | 0.57 |
| Solvency Ratio | -0.45 | -0.87 | -0.13 | -0.37 | -0.24 |
| Operating Cash Flow Ratio | -0.69 | -2.18 | -0.40 | -2.06 | -0.89 |
| Short-Term Operating Cash Flow Coverage | -13.54 | 0.00 | -0.73 | -42.90 | -6.44 |
| Net Current Asset Value | $ 310.80M | $ 235.26M | $ -312.90M | $ -262.96M | $ -108.55M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.05 | 0.05 | 0.30 | 0.26 | 0.41 |
| Debt-to-Equity Ratio | 0.07 | 0.07 | -0.66 | -1.26 | 1.18 |
| Debt-to-Capital Ratio | 0.07 | 0.07 | -1.97 | 4.84 | 0.54 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | -0.03 | -3.37 | 0.40 |
| Financial Leverage Ratio | 1.34 | 1.30 | -2.18 | -4.79 | 2.91 |
| Debt Service Coverage Ratio | -8.67 | -35.80 | -0.86 | -26.62 | -3.74 |
| Interest Coverage Ratio | -3588.65 | -52.85 | -16.77 | -26.83 | -17.65 |
| Debt to Market Cap | 0.01 | 0.00 | 0.36 | 0.71 | 0.24 |
| Interest Debt Per Share | 0.08 | 0.10 | 1.30 | 1.37 | 1.52 |
| Net Debt to EBITDA | 1.02 | 1.13 | -0.85 | -0.12 | -1.88 |
| Profitability Margins | |||||
| Gross Profit Margin | 49.86% | 48.31% | 47.44% | 37.83% | 53.13% |
| EBIT Margin | -113.30% | -77.39% | -65.49% | -192.55% | -45.82% |
| EBITDA Margin | -100.43% | -67.73% | -51.21% | -177.21% | -33.90% |
| Operating Profit Margin | -109.34% | -100.46% | -72.03% | -118.64% | -51.66% |
| Pretax Profit Margin | -113.33% | -79.29% | -69.78% | -196.97% | -48.75% |
| Net Profit Margin | -87.77% | -79.62% | -70.21% | -194.08% | -45.36% |
| Continuous Operations Profit Margin | -68.94% | -79.62% | -70.21% | -194.08% | -45.36% |
| Net Income Per EBT | 77.45% | 100.41% | 100.61% | 98.53% | 93.05% |
| EBT Per EBIT | 103.64% | 78.93% | 96.87% | 166.02% | 94.37% |
| Return on Assets (ROA) | -13.19% | -22.68% | -23.11% | -48.70% | -21.52% |
| Return on Equity (ROE) | -17.65% | -29.44% | 50.43% | 233.34% | -62.62% |
| Return on Capital Employed (ROCE) | -20.31% | -32.07% | -35.84% | -33.50% | -29.90% |
| Return on Invested Capital (ROIC) | -12.21% | -31.71% | -27.59% | -32.47% | -26.65% |
| Return on Tangible Assets | -13.19% | -29.42% | -34.67% | -70.03% | -42.04% |
| Earnings Yield | -15.33% | -22.50% | -42.67% | -207.49% | -19.94% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.35 | 5.19 | 5.41 | 5.67 | 7.13 |
| Payables Turnover | 7.91 | 7.34 | 6.05 | 7.69 | 5.77 |
| Inventory Turnover | 2.14 | 2.21 | 2.72 | 2.84 | 2.94 |
| Fixed Asset Turnover | 1.85 | 2.44 | 1.94 | 1.65 | 2.00 |
| Asset Turnover | 0.15 | 0.28 | 0.33 | 0.25 | 0.47 |
| Working Capital Turnover Ratio | 0.26 | 0.97 | 0.99 | 1.04 | 3.04 |
| Cash Conversion Cycle | 181.77 | 185.51 | 141.26 | 145.66 | 112.17 |
| Days of Sales Outstanding | 57.45 | 70.32 | 67.48 | 64.39 | 51.21 |
| Days of Inventory Outstanding | 170.45 | 164.90 | 134.09 | 128.70 | 124.19 |
| Days of Payables Outstanding | 46.12 | 49.72 | 60.32 | 47.43 | 63.22 |
| Operating Cycle | 227.90 | 235.22 | 201.58 | 193.10 | 175.39 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.19 | -0.41 | -0.55 | -1.14 | -0.58 |
| Free Cash Flow Per Share | -0.22 | -0.43 | -0.58 | -1.19 | -0.76 |
| Dividend Paid and CapEx Coverage Ratio | -8.95 | -17.17 | -15.29 | -23.36 | -3.32 |
| Capital Expenditure Coverage Ratio | -8.95 | -17.17 | -15.29 | -23.36 | -3.32 |
| Operating Cash Flow Coverage Ratio | -2.41 | -4.35 | -0.44 | -0.87 | -0.39 |
| Operating Cash Flow to Sales Ratio | -0.87 | -0.82 | -0.41 | -0.91 | -0.34 |
| Free Cash Flow Yield | -16.92% | -24.60% | -26.36% | -101.72% | -19.30% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -6.40 | -3.37 | -2.34 | -0.48 | -5.02 |
| Price-to-Sales (P/S) Ratio | 5.72 | 3.54 | 1.65 | 0.94 | 2.28 |
| Price-to-Book (P/B) Ratio | 1.15 | 1.31 | -1.18 | -1.12 | 3.14 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -5.91 | -4.07 | -3.79 | -0.98 | -5.18 |
| Price-to-Operating Cash Flow Ratio | -6.57 | -4.30 | -4.04 | -1.03 | -6.74 |
| Price-to-Earnings Growth (PEG) Ratio | 0.10 | 0.08 | 0.04 | -0.00 | -0.93 |
| Enterprise Value Multiple | -4.68 | -4.09 | -4.07 | -0.65 | -8.59 |
| Enterprise Value | 401.09M | 483.44M | 221.45M | 112.96M | 380.28M |
| EV to EBITDA | -4.68 | -4.09 | -4.07 | -0.65 | -8.59 |
| EV to Sales | 4.70 | 2.77 | 2.08 | 1.15 | 2.91 |
| EV to Free Cash Flow | -4.85 | -3.18 | -4.80 | -1.21 | -6.63 |
| EV to Operating Cash Flow | -5.39 | -3.37 | -5.12 | -1.26 | -8.63 |
| Tangible Book Value Per Share | 1.11 | 0.94 | -3.23 | -2.56 | -0.52 |
| Shareholders’ Equity Per Share | 1.11 | 1.34 | -1.87 | -1.04 | 1.25 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.39 | -0.00 | -0.01 | 0.01 | 0.07 |
| Revenue Per Share | 0.22 | 0.49 | 1.34 | 1.25 | 1.72 |
| Net Income Per Share | -0.20 | -0.39 | -0.94 | -2.43 | -0.78 |
| Tax Burden | 0.77 | 1.00 | 1.01 | 0.99 | 0.93 |
| Interest Burden | 1.00 | 1.02 | 1.07 | 1.02 | 1.06 |
| Research & Development to Revenue | 0.30 | 0.36 | 0.24 | 0.38 | 0.29 |
| SG&A to Revenue | 1.29 | 0.90 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.35 | 0.18 | 0.12 | 0.15 | 0.12 |
| Income Quality | 0.99 | 1.03 | 0.58 | 0.47 | 0.74 |
Currency in USD
